United States - English - NLM (National Library of Medicine)

ranbaxy pharmaceuticals inc. - nefazodone hydrochloride (unii: 27x63j94gr) (nefazodone - unii:59h4fcv1tf) - tablet - 50 mg - nefazodone hydrochloride tablets, usp is indicated for the treatment of depression. when deciding among the alternative treatments available for this condition, the prescriber should consider the risk of hepatic failure associated with nefazodone hydrochloride tablets, usp treatment (see warnings ). in many cases, this would lead to the conclusion that other drugs should be tried first. the efficacy of nefazodone in the treatment of depression was established in 6 to 8 week controlled trials of outpatients and in a 6-week controlled trial of depressed inpatients whose diagnoses corresponded most closely to the dsm-iii or dsm-iiir category of major depressive disorder (see clinical pharmacology ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks). it must include either depressed mood or loss of interest or pleasure and at least five of the following nine symptoms: depressed

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

link pharmaceuticals ltd - levomepromazine maleate - oral tablet - 6mg

Ireland - English - HPRA (Health Products Regulatory Authority)

hope pharmaceuticals ltd - sodium thiosulfate; sodium nitrite - solution for injection - 30/250 milligram(s)/millilitre - antidotes; thiosulfate; sodium nitrite

Ireland - English - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - pioglitazone hydrochloride - tablet - 30 milligram(s) - thiazolidinediones; pioglitazone

Ireland - English - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - pioglitazone hydrochloride - tablet - 45 milligram(s) - thiazolidinediones; pioglitazone

United States - English - NLM (National Library of Medicine)

ani pharmaceuticals, inc. - mexiletine hydrochloride (unii: 606d60is38) (mexiletine - unii:1u511hhv4z) - mexiletine hydrochloride capsules usp are indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life- threatening. because of the proarrhythmic effects of mexiletine, its use with lesser arrhythmias is generally not recommended. treatment of patients with asymptomatic ventricular premature contractions should be avoided. initiation of mexiletine treatment, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital. antiarrhythmic drugs have not been shown to enhance survival in patients with ventricular arrhythmias. mexiletine hydrochloride capsules are contraindicated in the presence of cardiogenic shock or preexisting second- or third-degree av block (if no pacemaker is present).

United States - English - NLM (National Library of Medicine)

ingenus pharmaceuticals, llc - mexiletine hydrochloride (unii: 606d60is38) (mexiletine - unii:1u511hhv4z) - mexiletine hydrochloride capsules, usp are indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening. because of the proarrhythmic effects of mexiletine, its use with lesser arrhythmias is generally not recommended. treatment of patients with asymptomatic ventricular premature contractions should be avoided. initiation of mexiletine treatment, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital. antiarrhythmic drugs have not been shown to enhance survival in patients with ventricular arrhythmias. mexiletine hydrochloride capsules are contraindicated in the presence of cardiogenic shock or pre-existing second- or third-degree av block (if no pacemaker is present).

United States - English - NLM (National Library of Medicine)

burel pharmaceuticals, llc - loxapine succinate (unii: x59sg0mryu) (loxapine - unii:ler583670j) - loxapine capsules are indicated for the treatment of schizophrenia. the efficacy of loxapine in schizophrenia was established in clinical studies which enrolled newly hospitalized and chronically hospitalized acutely ill schizophrenic patients as subjects. loxapine is contraindicated in comatose or severe drug-induced depressed states (alcohol, barbiturates, narcotics, etc.). loxapine is contraindicated in individuals with known hypersensitivity to dibenzoxazepines.

Ireland - English - HPRA (Health Products Regulatory Authority)

hope pharmaceuticals ltd - sodium nitrite; sodium thiosulfate - solution for injection - 30/250 milligram(s)/millilitre - antidotes; thiosulfate; sodium nitrite

United States - English - NLM (National Library of Medicine)

senores pharmaceuticals, inc. - mexiletine hydrochloride (unii: 606d60is38) (mexiletine - unii:1u511hhv4z) - mexiletine hydrochloride capsules, usp are indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening. because of the proarrhythmic effects of mexiletine, its use with lesser arrhythmias is generally not recommended. treatment of patients with asymptomatic ventricular premature contractions should be avoided. initiation of mexiletine treatment, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital. antiarrhythmic drugs have not been shown to enhance survival in patients with ventricular arrhythmias. mexiletine hydrochloride capsules are contraindicated in the presence of cardiogenic shock or preexisting second- or third-degree av block (if no pacemaker is present).